Role of inflammatory infiltrates in triple negative breast cancer

Journal of Clinical Pathology
Hirofumi MatsumotoJabed Iqbal

Abstract

Triple negative breast cancer (TNBC) is a heterogenous disease often characterised by aggressive biology and poor prognosis. Efforts to precisely treat TNBC have been compounded by the lack of specific therapeutic molecular targets. Recent transcriptomic studies have revealed, among others, an immunomodulatory subtype of TNBC, whereby activated immune response genes are associated with good prognosis. Since then, a great deal of effort has been made to understand the immune microenvironment of some TNBC subtype, which comprises several immune cell populations including lymphocytes and macrophages. There is increasing evidence that the basal subtype may be significantly regulated by tumour-infiltrating T-cells and that high levels of tumour-infiltrating CD8+ T-cells may be a reflection of improved prognosis with chemotherapy sensitivity in TNBC. On the other hand, tumour-associated macrophages have been associated with a relatively poor outcome in TNBC. Comparison of the immune signatures in TNBC with non-TNBC may furthermore help us to understand these immune mechanisms potentially leading to new therapeutic approaches. Within this short review, we discuss the current scientific evidence regarding (a) the role of tumour-infiltr...Continue Reading

References

Dec 1, 1976·Cancer·H L IoachimE Paluch
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
Jan 18, 2003·International Journal of Cancer. Journal International Du Cancer·Mitsuhiko IwamotoNobuhiko Tanigawa
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Jul 31, 2003·British Journal of Cancer·B J Coventry, J Morton
Feb 1, 2006·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ping Yu, Yang-Xin Fu
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gaynor J BatesAlison H Banham
Jan 31, 2007·Breast Cancer Research : BCR·Carine ChaveyGwendal Lazennec
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey S WolfBert W O'Malley
Apr 7, 2007·International Journal of Cancer. Journal International Du Cancer·Hazem GhebehSaid Dermime
Jan 4, 2008·Histopathology·J S Reis-Filho, A N J Tutt
Feb 19, 2008·Cancer Research·David SarrióJosé Palacios
Apr 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sylvain LadoireFrançois Ghiringhelli
Jun 19, 2008·Breast Cancer Research : BCR·Gabriella HonethCecilia Hegardt
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Khalid I Al-ShibliLill-Tove Busund
Sep 30, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sandra D Bohling, Kimberly H Allison
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Anita GrigoriadisA Munro Neville
Aug 25, 2009·Trends in Immunology·De YangJoost J Oppenheim
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten DenkertGunter von Minckwitz
Jun 18, 2010·Breast Cancer Research and Treatment·Sahar M A MahmoudAndrew R Green
Jul 9, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CuriglianoA Goldhirsch
Oct 26, 2010·Trends in Molecular Medicine·Yael S BarachXingxing Zang
Jan 20, 2011·BJU International·Malin E WinerdalOla Winqvist
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sahar M A MahmoudAndrew R Green
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Thomas KarnManfred Kaufmann
Oct 8, 2011·Breast Cancer Research : BCR·Achim RodyManfred Kaufmann
Nov 4, 2011·Journal of Clinical Pathology·S M A MahmoudA R Green
Dec 30, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Asis PalazónIgnacio Melero

❮ Previous
Next ❯

Citations

Jan 15, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Juanjuan HeXinguang Qiu
Nov 6, 2015·Trends in Pharmacological Sciences·Murugan KalimuthoKum Kum Khanna
Apr 6, 2016·Future Oncology·Giovanna TrecateRosaria Orlandi
Mar 16, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marijn A VermeulenCarolien H M van Deurzen
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Behrad DarvishiKeivan Majidzadeh-A
Mar 30, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jia-Mei ChenJuan Liu
Feb 9, 2018·Breast Cancer Research and Treatment·Padmashree RidaRitu Aneja
Apr 25, 2019·Journal of Cellular Physiology·Huang ZenanJia Changchang
Feb 10, 2018·Current Medicinal Chemistry·Andrea NicoliniAngelo Carpi
Apr 18, 2020·Cancer Communications·Wei Chang Colin TanTony Kiat Hon Lim
Jul 25, 2017·Journal of Clinical Pathology·Joe YeongPuay Hoon Tan
Apr 9, 2016·Oncotarget·Zhi-Qiang WangPeter H Watson
May 19, 2019·Clinical and Experimental Medicine·Guadalupe Avalos-NavarroAlicia Del Toro-Arreola
Jul 2, 2020·Cells·Yulia Liubomirski, Adit Ben-Baruch
Mar 20, 2016·Journal of Biomolecular Screening·Emma S HickmanBent K Jakobsen
Jun 1, 2018·Journal of Translational Medicine·Zehuan LiJin Wang
Nov 23, 2019·Integrative Cancer Therapies·Nurul Elyani MohamadNoorjahan Banu Alitheen
Jun 13, 2020·Frontiers in Oncology·Yanling HeJian Shi
Sep 29, 2019·Journal of Cancer Research and Clinical Oncology·H VihervuoriP Kronqvist
Oct 28, 2016·Breast Cancer Research and Treatment·Michael J CampbellLaura Esserman
May 13, 2017·International Journal of Oncology·Therése LindstenAnn Erlandsson
Aug 14, 2019·Virchows Archiv : an International Journal of Pathology·An Sen TanPuay Hoon Tan
Jul 8, 2020·Genome Biology·Jae Won YunPeter J Park
Aug 18, 2020·Science China. Life Sciences·Song-Yang WuYi-Zhou Jiang
Oct 6, 2020·Frontiers in Oncology·Margherita SonnessaAnita Mangia
Aug 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Julia Sperlich, Nicole Teusch
May 4, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angie M Torres-AdornoNaoto T Ueno
Apr 5, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Brittany D JenkinsMelissa B Davis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.